Trial Profile
Intracoronary Scaffold Assessment a Randomised Evaluation of Absorb in Myocardial Infarction (ISAR-Absorb MI) A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- Acronyms ISAR-Absorb; ISAR-Absorb MI
- 01 Oct 2021 Results (n=119) of subset of subjects enrolled in this trial who underwent OCT surveillance at time of routine angiographic follow-up at 6-8 months published in the International Journal of Cardiovascular Imaging
- 05 Dec 2018 Primary endpoint (Percentage Diameter Stenosis) has been met as per results published in the European Heart Journal
- 05 Dec 2018 Results published in the European Heart Journal